Pharma Times

MARCH 30, 2022

Report uses input from healthcare professionals to highlight training and support needs, while also warning about departures

139

139

pharmaphorum

MARCH 30, 2022

Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread and leading to an elevated risk of severe exacerbations. The results from the SABINA registry programme in more than a million people with the respiratory disease show that 40% of patients were over-using short-acting beta agonist (SABA) inhalers, which are used on demand to open up the airways.

115

115

Outsourcing Pharma

MARCH 31, 2022

A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.

105

105

NY Times

MARCH 29, 2022

People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies are also eligible.

Immunization 87

Immunization Immunity Vaccines 87

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

MARCH 31, 2022

In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication

114

114

pharmaphorum

MARCH 31, 2022

University College Dublin spinout Kinesis Health Technologies, which has developed a range of wearable sensors to assess the physical capabilities of patients, has been bought by US company Linus Health for an undisclosed sum. The merger brings together Kinesis’ gait analysis tools with Linus’ digital brain health monitoring technologies, designed to spot diseases like Alzheimer’s before over symptoms develop.

Hospitals 105

Hospitals 105

Drug Channels

APRIL 1, 2022

Today’s guest post comes from Fauzea Hussain, Vice President of Public Policy at McKesson. Fauzea succinctly describes the complicated and contradictory aspects of the Centers for Medicare & Medicaid Services' Final Rule on Best Price, a.k.a. the Medicaid copay accumulator rule. She then outlines how the rule, if implemented, is likely to hurt patients.

84

84

Pharma Times

MARCH 30, 2022

ProKnow was chosen to enable healthcare providers to benchmark treatment metrics against best practice and support clinical excellence

120

120

pharmaphorum

MARCH 28, 2022

Israel-based AION Labs and German independent research institute BioMed X announced its third global call for applications to form a new start-up company focused on using AI to design and optimise antibodies for targeted therapies. . Noga Yerushalmi, investment director at M Ventures (the venture arm of Merck), tells us how AION Labs was formed and aspires to help ease the pharma industry’s shared challenges by offering its vast resources a new start-up.

Compounding 98

Compounding 98

Outsourcing Pharma

MARCH 29, 2022

The agency's requested funding for FY 2023, nearly 34% higher than for FY 2022, calls for investments in public health modernization and pandemic preparation.

97

97

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

NY Times

MARCH 28, 2022

Jada Pinkett Smith’s hair loss condition played a major role in an incident at the Oscars. Here’s what we know about it.

98

98

Pharma Times

MARCH 28, 2022

Digital health boost as new website focuses on dry eye disease, which currently affects one in four people across the UK

117

117

pharmaphorum

APRIL 1, 2022

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the most significant piece of NHS legislation in a decade. The new bill, which is expected to come into force on 1st July, will see Clinical Commissioning Groups replaced with Integrated Care Systems (ICSs) as statutory bodies across England.

98

98

Eye on FDA

MARCH 30, 2022

Tectonic pandemic plates are shifting respecting the COVID-19 pandemic. For weeks now we have been watching caseloads in the United States broadly fall. It feels as if we are indeed shifting gears. There are other moving parts that are in motion as well. It is a fundamental re-shifting of the landscape. And there are consequences. First, government funding supporting access to vaccination and treatment for COVID has run out and so far, is not replenished.

Vaccines 76

Vaccines 76

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

NY Times

MARCH 30, 2022

Taking these seven steps now can lower your risk and minimize the disruption to your family’s life.

Immunization 105

Immunization Immunity Vaccines 105

Pharma Times

APRIL 1, 2022

Study demonstrates ability of the Parsortix system to isolate circulating tumour cells, targeting the metastatic spread of cancer

110

110

pharmaphorum

MARCH 31, 2022

Leading tennis players train two to three hours a day to prepare for tournaments and have daily coaching input to make them game ready. It’s a gruelling regime but the rewards are obvious. Competing at the top level in pharma sales could be developed by following in the fast footsteps of Roger Federer and Rafael Nadal. Experts believe time spent practising delivery and messaging will reap dividends providing it is grooved into a sales force or medical science liaison (MSL) team’s schedule.

Communication 97

Communication Hospitals 97

Drug Channels

MARCH 29, 2022

Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. Broadcast live on April 22, 2022 , from 12:00 p.m. to 1:30 p.m. ET This page describes the event and explains how to purchase a registration to participate in the event.

Specialty Pharmacies 72

Specialty Pharmacies 72

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

NY Times

MARCH 30, 2022

“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said.

Hospitals 98

Hospitals 98

Pharma Times

APRIL 1, 2022

New technology could reduce finger pricking by 50% while also providing patients with continuous data about blood sugar levels

Diabetes 106

Diabetes 106

pharmaphorum

MARCH 31, 2022

By a narrow margin, an FDA advisory committee has voted against approval of Amylyx’ experimental medicine for amyotrophic lateral sclerosis until the company can provide more evidence that it is effective. The prospects of a positive vote on AMX0035 (sodium phenylbutyrate and taurursodiol) were looking dim after the FDA expressed its doubts about the efficacy data in Amylyx’ single 140-subject study, although the desperate need for new treatments for ALS had the company hopeful it ha

97

97

Drug Channels

MARCH 28, 2022

Informa Connect’s Medicaid & Government Pricing Congress. Hybrid Event In-Person: May 23-25, 2022, Philadelphia, PA | Virtual: June 1-2, 2022 www.informaconnect.com/medicaid-government-pricing. Don’t miss the Medicaid & Government Pricing Congress , coming up May 23-25, 2022 (in-person in Philadelphia) and June 1-2, 2022 (virtually)! You'll be part of the important discussions surrounding the critical policy updates and approaches to effectively contract, report and comply with state and

Drug Pricing 67

Drug Pricing 67

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

NY Times

MARCH 30, 2022

With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.

59

59

Pharma Times

MARCH 28, 2022

Collaboration between Babylon Health and tech giant seeks to speed up historically slow patient access to data

114

114

pharmaphorum

MARCH 27, 2022

Johnson & Johnson is in course for approval of its multiple myeloma CAR-T therapy Carvykti in the EU the next few weeks, after getting a green light from the EMA’s human medicines committee. The CHMP recommended conditional approval for Carvykti (ciltacabtagene autoleucel or cilta-cel) as a treatment for adults with relapsed and refractory multiple myeloma who have received at least three prior therapies and whose cancer is worsening.

Labelling 96

Labelling Immunity Immunization 96

Drug Channels

MARCH 31, 2022

Ah, it’s finally spring in downtown Philadelphia, our home base. (Photographic evidence on your right.) Along with sunshine and fine weather, this vernal equinox has ushered in a crop of new and noteworthy stories: Health inequities in utilization management Insurers compute big white bagging savings The biosimilar boom accelerates The patient upside of manufacturers’ copay support Whoa.

Biosimilars 81

Biosimilars 81

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

APRIL 1, 2022

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Times

MARCH 29, 2022

Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval

108

108

pharmaphorum

MARCH 30, 2022

Roche has suffered a setback with its much-anticipated pairing of anti-TIGIT antibody tiragolumab and PD-L1 inhibitor Tecentriq in small cell lung cancer (SCLC), in a blow to its ambitions in combination cancer immunotherapy. The SKYSCRAPER-02 showed that the combination of the two drugs given on top of chemotherapy was unable to improve progression-free survival versus Tecentriq (atezolizumab) plus chemo in extensive-stage SCLC – a notoriously hard-to-treat form of lung cancer.

Chemotherapy 94

Chemotherapy Immunity Immunization 94

Pharmacy Joe

MARCH 30, 2022

In this episode, I’ll discuss whether melatonin can prevent ICU delirium. Episode 700: Can melatonin prevent ICU delirium? Subscribe on iTunes , Android , or Stitcher Numerous medications have been studied in an attempt to find something that prevents the development of ICU delirium. Studies involving melatonin have produced mixed results, and a group of authors from Australia sought to determine via a high quality randomized controlled trial whether melatonin can prevent the development of ICU

Hospitals 52

Hospitals Inpatient 52

Drug Patent Watch

APRIL 1, 2022

Annual Drug Patent Expirations for AMONDYS+45 Amondys 45 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Sarepta Theraps drug AMONDYS 45 appeared first on DrugPatentWatch - Make Better Decisions.

52

52